SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The company declared distributions payable on or about August 10, 2026, to stockholders of record as of July 31, 2026, across six classes of common stock with net distribution amounts ranging from $0.1480 to $0.2168 per share.
View raw filing on EDGAR →Mr. Thierry Bernard resigned from the Board of Directors of Neogen Corporation on August 3, 2026. This is a clear departure of a director, which is material to investors as board composition affects governance and oversight. The disclosure is straightforward and unambiguous.
View raw filing on EDGAR →Athene Holding Ltd. issued $1,000,000,000 aggregate principal amount of 6.150% Senior Notes due 2036 on August 7, 2026, pursuant to an Underwriting Agreement with major underwriters including Wells Fargo Securities, Barclays, BofA Securities, and Citigroup.
View raw filing on EDGAR →State Street modified the rights of security holders through an amendment to its Articles of Organization establishing the terms of a new Series L preferred stock.
View raw filing on EDGAR →State Street entered into an underwriting agreement on August 5, 2026, to issue and sell 500,000 depositary shares representing Series L preferred stock in a public offering, with expected net proceeds of approximately $495.7 million.
View raw filing on EDGAR →Global Self Storage disclosed its financial results for the second quarter and first half ended June 30, 2026, via an earnings press release. The disclosure includes Q2 and first-half 2026 highlights, detailed financial summaries, same-store results, operating results, FFO and AFFO metrics, and management commentary on operational performance, occupancy, tenant duration, and capital resources.
View raw filing on EDGAR →BioStem announced its uplisting from the OTC Basic Market to The Nasdaq Capital Market, effective August 7, 2026, with trading commencing under ticker "BSEM." This is a material operational and strategic milestone that improves market visibility, liquidity, and access to capital for the company and its shareholders. While not a traditional M&A transaction or governance change, the uplisting is a significant corporate event that would affect a reasonable investor's assessment of the registrant's market position and future prospects.
View raw filing on EDGAR →BCP Investment Corporation issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing net investment income of $5.5 million ($0.45 per share), NAV of $179.5 million ($14.49 per share), and portfolio composition details. This is a standard quarterly earnings release filed under Item 2.02 with exhibits 99.1 and 99.2 attached, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →The 6-K discloses an amendment to the Company's loan and share pledge agreements dated July 14, 2026, whereby the Bond Holder refinanced JPY 275,000,000 in convertible bonds into a new loan, increasing total debt under the Loan Agreement to JPY 475,000,000. This represents a material modification of the Company's direct financial obligations and creation of additional debt, fitting the debt_issuance category. The refinancing also extends the maturity and secures the obligation with a first-priority pledge of subsidiary shares, which would affect a reasonable investor's assessment of the registrant's capital structure and financial risk.
View raw filing on EDGAR →Southwest Airlines' Compensation Committee approved changes to annual base salaries and long-term incentive opportunity targets for named executive officers, effective August 15, 2026, including specific adjustments for CEO Bob Jordan and four other senior executives, with the Committee citing the need to realign compensation with the largest three U.S. airline peers to address retention risks.
View raw filing on EDGAR →Interactive Strength issued 798,719 shares of Common Stock through a series of exchange agreements with preferred stockholders and note holders between August 3–7, 2026, relying on Section 3(a)(9) exemption from registration. This is a material unregistered equity issuance that increases share count from approximately 581,677 to 1,380,396 shares outstanding—a 137% dilution—and would materially affect a reasonable investor's assessment of ownership and voting power.
View raw filing on EDGAR →The filing discloses an unregistered sale of 1,060,552.7919 common shares for $26.771 million in aggregate consideration under Section 4(a)(2) and Regulation D Rule 506. This is a classic private placement of equity securities exempt from registration, which is material to investors as it represents dilution and capital raising activity. The Item 3.02 designation and detailed breakdown of share classes and consideration confirm this is a dilutive equity issuance.
View raw filing on EDGAR →Red Violet completed a registered public offering of 1,916,667 shares of common stock (including full exercise of the underwriters' 15% option) at $60 per share on August 7, 2026, raising approximately $108.6 million in net proceeds. The offering was underwritten and registered on Form S-3, with proceeds intended for working capital, general corporate purposes, and potential strategic acquisitions.
View raw filing on EDGAR →The 8-K Item 8.01 discloses the transcript of Liquidity Services' earnings conference call held on August 6, 2026, presenting Q3 fiscal 2026 financial results. The call includes detailed discussion of GAAP diluted EPS of $0.32 (up 39% YoY), GMV growth of 10% to $453 million, revenue growth of 8% to $129.6 million, and Adjusted EBITDA growth of 30% to $22 million, along with segment-level performance and forward guidance for Q4 2026. This is a standard earnings release disclosure furnished as an exhibit.
View raw filing on EDGAR →The Board adopted the Ondas Inc. 2026 Inducement Plan reserving 20,000,000 shares for equity awards including stock options, RSUs, restricted stock, and performance-based awards. This is a compensatory arrangement for officers and directors under Item 5.02(e), establishing the framework for future equity-based compensation. The materiality is high given the substantial share reserve and broad scope of potential awards.
View raw filing on EDGAR →Sabre amended its accounts receivable securitization facility, increasing the overall size from $115 million to $130 million, extending the maturity date to September 28, 2029, and adding Sabre Asia Pacific PTE. Ltd. as a new originator. This amendment expands borrowing capacity and restructures the terms of the AR Facility, a material modification to the company's direct financial obligations.
View raw filing on EDGAR →ReNew Energy announces receipt of a "Best and Final Proposal" from a Consortium led by CPP Investments and founder Sumant Sinha to acquire the entire issued and to-be-issued share capital of the Company not already owned by Consortium members, at US$7.02 per share. This is a material acquisition proposal under active evaluation by the Special Committee, representing a potential change of control transaction that would materially affect the registrant's future.
View raw filing on EDGAR →Shareholders approved four proposals at the 2026 Annual Meeting held on August 6, 2026: election of two Class I directors (Shapiro and Wishart-Smith, each approved by over 93%), a say-on-pay advisory vote (approved by over 95%), ratification of BDO USA as independent auditor (approved by over 99%), and approval of the Amended 2016 Omnibus Incentive Plan (approved by over 82%).
View raw filing on EDGAR →Apollo Debt Solutions BDC completed a $514.9 million term debt securitization (CLO) on August 6, 2026, through its subsidiary ADL CLO 3 LLC, issuing multiple tranches of secured notes and loans including $248.7M Class A-1a Notes, $20.6M Class A-1b Notes, $30.9M Class A-2 Notes, $41.2M Class B Notes, $30.9M Class C Notes, $50M Class A-1a Loans, and $92.6M Subordinated Notes. This material creation of new direct financial obligations represents a significant financing arrangement for the BDC.
View raw filing on EDGAR →Gayatri Narayan, President of Technology and Digital Solutions, was notified of separation effective August 14, 2026. While the disclosure mentions severance benefits under the Executive Severance Plan, the principal disclosed action is the departure of a named executive officer from her position. The filing emphasizes the separation event itself, making exec_departure the most salient classification.
View raw filing on EDGAR →Dr. Erica Schwartz, a Class III independent director and Chair of the Clinical Quality Committee, resigned from Aveanna Healthcare's Board of Directors effective immediately on August 5, 2026, due to her nomination and confirmation as Director of the U.S. Centers for Disease Control and Prevention. This is a clear executive departure—the principal disclosed action is a director leaving the board. The resignation of a board chair, particularly one overseeing clinical quality at a healthcare company, is material to investors.
View raw filing on EDGAR →The filing discloses the election of Danny Deep, the current president of General Dynamics, to the board of directors effective August 5, 2026. This is a clear executive appointment to a governance role. While Deep already serves as president and receives no additional compensation for the board seat, the principal disclosed action is his appointment as a director, which is material to investors as it reflects board composition changes and governance structure at a major defense contractor.
View raw filing on EDGAR →The filing discloses a material acquisition activity: Kensington Capital Acquisition Corp. VI and Nth Cycle, Inc. have entered into a Business Combination Agreement (dated July 21, 2026) and announced confidential submission of a draft Form S-4 registration statement on August 7, 2026. The transaction values Nth Cycle at an implied enterprise value of $585 million and contemplates a merger resulting in a combined company named Nth Cycle Holdings, Inc. to be listed on NYSE. This is a classic SPAC merger—a material change of control requiring shareholder approval.
View raw filing on EDGAR →The filing discloses a secondary offering of 20,000,000 shares of Class A Common Stock by a major stockholder (One Rock Capital Partners affiliate) that closed on August 7, 2026, generating $487.4 million in gross proceeds. While technically a secondary offering (shares sold by an existing stockholder rather than a primary issuance by the company), the substantial volume and market impact qualify this as a material capital event. The company also entered into a concurrent stock repurchase agreement to buy back 410,340 shares at the offering price, which is a related capital transaction. This disclosure under Item 1.01 (Material Definitive Agreement) reflects the company's involvement in the underwriting agreement and the repurchase agreement, making it a material event affecting share structure and investor interests.
View raw filing on EDGAR →This exhibit is a press release announcing Emera Inc.'s 2026 second quarter financial results, disclosing Q2 2026 adjusted EPS of $0.69 and reported EPS of $0.34, along with year-to-date results and segment performance. The document explicitly states "Emera Reports 2026 Second Quarter Financial Results" and provides detailed financial metrics, segment results, and forward-looking guidance, which are hallmarks of an earnings release.
View raw filing on EDGAR →Arcadia Biosciences received a formal notice from Nasdaq on August 4, 2026, that it has failed to satisfy the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). The company has been granted a 180-day compliance period until February 1, 2027, to regain compliance, with the explicit risk that failure to do so could result in delisting. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →This disclosure describes entry into a material definitive merger agreement between Pono Capital Four, Inc. (a SPAC) and Blackstar Orbital Technologies Corporation, an aerospace technology company. The agreement contemplates a business combination whereby Merger Sub will merge with Blackstar, with Blackstar becoming a wholly-owned subsidiary of PONO (to be renamed Blackstar Orbital Corporation). The transaction involves a $380 million base purchase price and is subject to customary closing conditions including shareholder approval and regulatory clearance. This is a classic material acquisition/change of control transaction under Item 1.01.
View raw filing on EDGAR →This exhibit discloses Amendment No. 1 to a Prepaid Share Forward agreement between Polibeli Group Ltd and three Harraden Circle investment entities, dated July 31, 2026. The amendment modifies the "Valuation Date" term of an underlying prepaid share forward transaction originally dated May 28, 2025, relating to a business combination closed in September 2024. The amendment grants the Seller discretion to specify the valuation date (with a 24-month maturity cap from the business combination closing), materially altering the timing and conditions of a financial derivative or forward contract. While this is a financial obligation modification, it does not fit neatly into debt_issuance, covenant_breach, or other specific financial event types; it is a material amendment to an existing financial arrangement that would affect investor assessment of the registrant's capital structure and contingent liabilities.
View raw filing on EDGAR →The 6-K discloses the appointment of two new directors effective August 7, 2026: Ms. Hsu Hui Chen as director and co-chief executive officer, and Ms. Lim Fei Fern as independent director and chairperson of the Compensation Committee. While the filing also reports concurrent resignations of three directors (Wu Wai Kong, Mhlengi Prevail Mafu, and Chung Wai Wong), the principal disclosed action is the appointment of the new directors to fill those vacancies, making this an exec_appointment event. The appointment of a co-CEO and multiple committee members is material to investor assessment of governance and leadership.
View raw filing on EDGAR →This disclosure announces a material joint venture transaction in which Indonesia's sovereign wealth fund (PT Danantara Investment Management) invests USD 2.5 billion for a 25% stake in a newly formed holding company that will own JBS's Australia and New Zealand businesses and pursue protein-sector acquisitions across Southeast Asia, Australia, and New Zealand. The transaction involves contribution of existing business assets, equity subscription, governance rights, and a potential USD 2.5 billion debt raise, totaling USD 5 billion in capital deployment. This constitutes a material change of control and capital structure event requiring disclosure under Item 1.01 (Business Combination) or Item 5.01 (Changes in Control).
View raw filing on EDGAR →This exhibit is a press release announcing Purple Biotech's second quarter 2026 financial results, including condensed consolidated interim financial statements for the three and six months ended June 30, 2026. The disclosure includes R&D and G&A expenses, operating loss, net income/loss, cash position ($6.1 million), and cash runway through mid-2027. While the company is clinical-stage and pre-revenue, the financial results and cash runway disclosure are material to investors assessing the registrant's financial condition and ability to fund operations.
View raw filing on EDGAR →The announcement describes a 16-for-1 reverse split of ADSs (from 1 ADS per 375 shares to 1 ADS per 6,000 shares), effective August 27, 2026. While reverse splits are typically capital-structure adjustments rather than dilutive issuances, the repeated ADS ratio changes (this is the second in three months) and the context of a foreign private issuer with a Nasdaq listing suggest potential financial distress or stock-price support measures. However, the exhibit does not disclose new equity issuance, private placement, or convertible securities—it is purely a mechanical ADS consolidation. The classification is uncertain because reverse splits do not fit neatly into the taxonomy; they are neither a discrete event nor a periodic report, and the materiality depends on whether the market interprets this as a distress signal.
View raw filing on EDGAR →The press release announces completion of a US$20 million share repurchase program (2025 Repurchase Program) and authorization of a new US$20 million repurchase program (2026 Repurchase Program). Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The disclosure of a new US$20 million authorization is material to investors assessing capital allocation strategy and shareholder returns.
View raw filing on EDGAR →iOThree Ltd is soliciting shareholder approval for an Extraordinary General Meeting scheduled for August 21, 2026, to vote on four material proposals: an increase in authorized share capital, a reverse stock split (1-for-8), a share consolidation (1-for-2 to 1-for-50 range), and amendments to the memorandum and articles of association.
View raw filing on EDGAR →This exhibit is a monthly operational update disclosing Bitcoin production metrics (112 BTC in July), hashrate capacity (14.2 EH/s), and power infrastructure (255 MW) for a Bitcoin mining company. While it reports production figures, it is not a formal earnings release with comprehensive financial results, but rather a routine operational metrics disclosure. However, the material decrease in Bitcoin holdings (from 1,671 to 1,314 BTC) driven by strategic capital deployment for future hashrate capacity, combined with the company's stated strategy to restore hashrate to ~20 EH/s, represents material operational and capital allocation activity that would affect a reasonable investor's assessment of the company's growth trajectory and financial position.
View raw filing on EDGAR →The filing discloses that Jerash Holdings' board of directors declared a regular quarterly dividend of $0.05 per share, payable on August 24, 2026 to stockholders of record as of August 17, 2026. This is a straightforward dividend distribution announcement disclosed under Item 7.01 (Regulation FD Disclosure) with supporting press release. While routine, dividend declarations are material to shareholders as they represent a return of capital and affect investment returns.
View raw filing on EDGAR →Barry M. Gosin, who has served as CEO since 1979, is stepping down from that role effective December 31, 2026. While the filing also discloses an amended employment agreement keeping him as Chairman of the operating company through 2029, the principal disclosed action is his departure from the CEO position—a material executive departure for a long-tenured leader of a publicly traded company. The amended compensation arrangement is secondary to the departure itself.
View raw filing on EDGAR →This Item 1.01 discloses amendments to the Business Combination Agreement between SVAQ and EigenQ, Inc., dated August 6, 2026. The amendments modify material terms of the proposed merger, including clarifications on share redemptions, board composition expansion from 7 to 9 members, and equity incentive plan reserve sizing. The filing also amends the Sponsor Support Agreement. These are material amendments to a definitive agreement governing a business combination transaction that will result in EigenQ becoming a wholly-owned subsidiary of SVAQ (PubCo), constituting M&A activity under Item 1.01.
View raw filing on EDGAR →This press release announces the adjournment of an Extraordinary General Meeting (EGM) originally scheduled for August 7, 2026, to December 1, 2026. The adjournment relates to a proposed share consolidation that the Company has determined "may not be necessary at this time" as it reassesses Nasdaq listing compliance. While the adjournment itself is a procedural governance matter, the underlying reason—reconsideration of a material capital structure change (share consolidation)—and the Company's stated need to "evaluate available options" suggests potential delisting risk or listing compliance concerns that would be material to investors. The governance classification is appropriate because the primary disclosed action is the meeting adjournment and shareholder voting procedures, though the materiality reflects the serious compliance context.
View raw filing on EDGAR →The filing discloses that Niki BioSolutions received a Nasdaq deficiency letter on March 5, 2026 for failing to maintain the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), triggering a 180-day compliance period. The August 4, 2026 letter confirms the Company has regained compliance by maintaining a closing bid price of $1.00 or greater for 10 consecutive business days. This is a delisting-risk disclosure—the Company faced potential delisting and has now resolved the deficiency, making it material to investors' assessment of the registrant's continued listing status.
View raw filing on EDGAR →Reitar Logtech Holdings Ltd is soliciting shareholder approval for a 25-for-1 reverse share split (share consolidation) and related charter amendments at an Extraordinary General Meeting scheduled for September 3, 2026. The reverse split represents a material capital structure change requiring shareholder authorization.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting held on August 7, 2026, where shareholders voted on six proposals. All proposals were approved by overwhelming majorities (99.8% for each), including authorization to increase authorized share capital from US$19.8M to US$495M, amendments to the memorandum and articles of association (including Class B share voting rights increased to 100 votes per share), and authorization for share consolidations at a 5-for-1 to 250-for-1 ratio. This is a classic shareholder_vote_results disclosure with material governance and capital structure implications.
View raw filing on EDGAR →The auditor's report explicitly states "the Company does not have sufficient cash and working capital to sustain its operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern." This is the unmistakable language of a going-concern disclosure, which is a material event that would affect a reasonable investor's assessment of the registrant's viability, despite the company having just completed a $172.5 million IPO.
View raw filing on EDGAR →Ebang completed the acquisition of a 461-acre property in North Carolina for approximately $24.6 million on August 5, 2026. The filing explicitly describes this as an "acquisition" and states the transaction consideration, indicating a material acquisition of real property. The company characterizes it as intended to "enhance operational capabilities" and "explore new business growth drivers," signaling strategic importance. This constitutes a material acquisition activity reportable under Item 1.01 or 2.01 of Form 8-K equivalents.
View raw filing on EDGAR →Rocky Mountain Chocolate Factory held its Annual Meeting on June 26, 2026, with shareholder voting results on five proposals: election of five directors, ratification of auditors (Rosenberg Rich Baker Berman, P.A.), advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and approval of an amendment to the 2024 Omnibus Incentive Compensation Plan increasing authorized shares by 530,000. All proposals passed with 82.35% of shares represented at the meeting.
View raw filing on EDGAR →Nexera has entered into a letter of intent with Nebo Holdings Limited to become the exclusive worldwide reseller and distributor of Preempt OSINT, a darknet intelligence platform for data center operators. This is a material strategic partnership and distribution arrangement that expands Nexera's business into the homeland security sector through a new product line, contemplating a 36-month exclusive license term with potential 24-month extension. While the LOI is non-binding in certain respects and subject to conditions (technical proof of concept, due diligence, board approvals), the exclusive distribution rights to a proprietary platform represent a significant operational and commercial development that would affect a reasonable investor's assessment of the company's growth prospects and strategic direction.
View raw filing on EDGAR →T1 Energy issued 13,615,979 shares of common stock to Evervolt as consideration for an intellectual property purchase on July 28, 2026. Although the prospectus supplement filed on August 7, 2026 covers resale by the holder (not a direct new issuance by the Company), the underlying event is a material unregistered equity issuance that dilutes existing shareholders. The shares were issued as acquisition consideration and are now registered for resale, creating significant dilution and liquidity risk typical of dilutive issuances disclosed under Item 3.02 or Item 8.01.
View raw filing on EDGAR →The Item 5.02 disclosure centers on the completion of a material separation and spin-off of the ADI Global Distribution business from Resideo, effective August 3, 2026, structured as a tax-free pro rata distribution of ADI common stock to Resideo shareholders. While the Item nominally addresses compensatory arrangements (anti-dilution adjustments to equity plans), the substantive event disclosed is the separation transaction itself—a change of control and disposition of a major business segment. The pro forma financial statements confirm ADI represented approximately 60% of historical revenues, making this a material M&A activity (disposition/spin-off) rather than a routine equity plan adjustment.
View raw filing on EDGAR →The filing discloses the Board's unanimous appointment of Ben Wiesenfeld as Chief Compliance Officer effective August 3, 2026, succeeding Scott Betz. While Betz transitions to Chief Operating Officer, the principal disclosed action centers on Wiesenfeld's appointment to the CCO role. As a BDC, compliance officer appointments are material governance events affecting investor assessment of regulatory oversight and internal controls.
View raw filing on EDGAR →Firefly Neuroscience held its Annual Meeting of Stockholders on August 5, 2026, and reported voting results for six proposals: director election, auditor ratification, executive compensation approval, equity plan amendment, certificate of incorporation amendment, and meeting adjournment, with specific vote tallies disclosed for each.
View raw filing on EDGAR →